Phase 1 Study of Trastuzumab Administered as a Single Intravenous Infusion
Clinical trial NCT02594761 · COMPLETED
Trial details
- NCT number
- NCT02594761
- Sponsor
- Mylan Pharmaceuticals Inc
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2013-08-01
- Primary completion
- 2014-02-01
- Enrollment
- 132
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.